From fiction to science: clinical potentials and regulatory considerations of gene editing

From fiction to science: clinical potentials and regulatory considerations of gene editing

Abstract Gene editing technologies such as CRISPR/Cas9 have emerged as an attractive tool not only for scientific research but also for the development of medicinal products. Their ability to induce precise double strand breaks into DNA enables targeted modifications of the genome including selectiv...

Full description

Bibliographic Details
Main Authors: Maria Schacker, Diane Seimetz
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Clinical and Translational Medicine
Subjects:
Gene editing
Gene therapy
Drug development
Regulatory strategy
Clinical trials
Artificial intelligence
Online Access:http://link.springer.com/article/10.1186/s40169-019-0244-7

Internet

http://link.springer.com/article/10.1186/s40169-019-0244-7

Similar Items